CompoAtlas

Ginkgo Biloba et Marc de Raisin Bio

Food supplement declared in France, declaration No 2023-3-724

Ginkgo Biloba et Marc de Raisin Bio (AMOSEEDS) is a food supplement declared in France. Status: withdrawn from the market on 28 November 2023. Main ingredients: Ginkgo biloba 550 mg per day, Vitis vinifera 150 mg per day. 1 rule of use applies to its ingredients (limits and warnings).

Brand
AMOSEEDS
Food business operator placing the product on the market
Amoseeds SAS
Status
Withdrawn from the market on 28 November 2023
Form
Capsule
Daily dose
2 gélules
Directions for use
Prendre 2 gélules par jour : 1 le matin et 1 le soir.
Not recommended (according to the manufacturer)
Adolescents (under 18), Breastfeeding women, Children (under 12), Young children (aged 1 to 3), Pregnant women, Infants (under 1 year), Taking anticoagulants, Taking blood pressure medication, Children (under 6), Children (under 10)
Objectives stated by the manufacturer (these are not authorised claims)
Eye / Vision, Nervous system, Blood and lymphatic circulation, Concentration

Declaration 315810, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Plants

PlantPartPreparationPer day
Ginkgo biloba L.FeuilleAutre extrait sec550 mg
Vitis vinifera L.MarcAutre extrait sec150 mg

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Label warnings

Ne doit en aucun cas remplacer un traitement médical. Déconseillé aux enfants et adolescents de moins de 18 ans, aux femmes enceintes, allaitantes, en cas d'hypertension artérielle et de traitement anticoagulants ou bêta-bloquants. Consultez votre médecin si vous êtes sous tout autre traitement médical. Ne pas dépasser la dose journalière conseillée. Tenir hors de portée des enfants. À conserver à température ambiante, au sec et à l'abri de la lumière. À consommer dans le cadre d'une alimentation saine, équilibrée.

Regulatory points

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Ginkgo biloba L.
    Read the warning, when it applies and the studies cited

    GINKGO - GINKGO BILOBA

    Route of administration: Oral

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding (Blumenthal et al. 2000; WHO 1999).

    Sources cited by Health Canada (3)
    • Blumenthal M, Goldberg A, Brinkmann J, editors. Herbal Medicine: Expanded Commission E Monographs. Newton (MA): Integrative Medicine Communications; 2000.
    • WHO 1999: World Health Organization. WHO monographs on selected medicinal plants, Volume 1. Geneva (CHE): World Health Organization; 1999.
    • OMS 1999 : Organisation mondiale de la santé (OMS). Monographs on selected medicinal plants, Volume 1. Genève (CHE): Organisation mondiale de la santé; 1999.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking diabetes, high blood pressure or seizure medications (Brinker 2010).

    Sources cited by Health Canada (1)
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.

    Contraindications

    Do not use if you are having a surgery (Gardner and McGuffin 2013).

    Sources cited by Health Canada (1)
    • Gardner Z, McGuffin M, editors. American Herbal Products Association's Botanical Safety Handbook. Second Edition. Boca Raton (FL): Taylor and Francis Group; 2013.

    Do not use if you are taking blood thinners or other health products that affect blood coagulation (Gardner and McGuffin 2013; Brinker 2010; Bent 2005).

    Sources cited by Health Canada (3)
    • Bent S, Goldberg H, Padula A, Avins AL. Spontaneous bleeding associated with ginkgo biloba: a case report and systematic review of the literature. Journal of General Internal Medicine 2005;20(7):657-661. PubMed Systematic review
    • Brinker F. Herb Contraindications and Drug Interactions, 4th edition. Sandy (OR): Eclectic Medical Publications; 2010.
    • Gardner Z, McGuffin M, editors. American Herbal Products Association's Botanical Safety Handbook. Second Edition. Boca Raton (FL): Taylor and Francis Group; 2013.

    Health Canada monograph dated 25 July 2025

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Other declarations with the same name

In France, every company that markets a supplement declares it, so one product can have several declarations (new formula, another distributor, an older declaration withdrawn). Each line compares the declared composition with this page.

Brand : AMOSEEDS

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “Ginkgo Biloba et Marc de Raisin Bio (AMOSEEDS): composition and regulation”, https://compoatlas.com/en/supplements/products/315810-ginkgo-biloba-et-marc-de-raisin-bio, updated 15 November 2026.

Enter to analyse, Shift+Enter for a new line